Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Irish Stock Exchange  >  Malin Corporation plc    MLCM   IE00BVGC3741

MALIN CORPORATION PLC (MLCM)
Mes dernières consult.
Most popular
Report
 SummaryChartsNewsCalendarCompany 
Quotes 5-day view   End-of-day quote. End-of-day quote Irish Stock Exchange
10/16/2017 10/17/2017 10/18/2017 10/19/2017 10/20/2017 Date
11 10.68 10.68 10.68 11.1 Last
2200 4000 0 3200 98920 Volume
-3.08% -2.91% 0.00% 0.00% +3.93% Change
Company
Malin Corp. Plc. is a global life sciences company.It acquires majority or significant minority equity positions in private, pre-Initial Public Offering, and pre-trade operating businesses in the life sciences industry particularly therapeutics, devices, and diagnostic companies.The company was... 
Sector
Pharmaceuticals
Calendar

- No events available -

More about the company
Latest news on MALIN CORPORATION PLC
10/19 MALIN : appoints Dr. Andrew von Eschenbach, former FDA commissioner, as Chief Me..
10/10 MALIN : appoints Dr. Andrew von Eschenbach, former FDA commissioner, as Chief Me..
10/10 MALIN CORPORATION PLC : appoints Dr. Andrew von Eschenbach, former FDA commissio..
08/31 MALIN : Announces U.S. FDA Approval for New Hourglass™ Peripheral Embolisa..
08/22 MALIN : Announces U.S. FDA Approval for New Hourglass™ Peripheral Embolisa..
04/20 MALIN : Novan Reports Positive Topline Results with SB208 in Phase 2 Trial
02/15 MALIN : Investment in Artizan Biosciences
02/15 MALIN : Investment in Wren Therapeutics
02/06 MALIN : Makes Significant Commitment to Artizan Biosciences, Inc.
01/17 MALIN : Irish biotech investment firm Malin buys stake in U.K.'s Wren Therapeuti..
More news
Sector news : Pharmaceuticals - NEC
10/20DJMERCK AND : to Lay Off About 1,800 U.S. Sales Reps in Cost-Cutting Move
10/20 MERCK AND : to cut 1,800 U.S. sales jobs, add 960 in chronic care
10/20DJABBOTT LABORATORIES : Hacking Is a Risk for Pacemakers. So Is the Fix
10/19DJCELGENE : Halts Crohn's Disease Drug Trials
10/19DJEuropean Corporate Roundup for Thursday
More sector news : Pharmaceuticals - NEC
Latest Tweets
10/18Novan secures rights to nitric oxide for certain oncovirus applications from .. 
10/18$NOVN: Novan announces completion of acquisition of KNOW Bio for an undisclos.. 
10/18Novan Acquires IP Rights to Treat Viral Malignancies with Nitric Oxide  
10/18BRIEF-Novan acquires IP rights to treat viral malignancies with nitric oxide .. 
10/16Strong winds along Donegal coasts as wind speeds of 102km/h recorded at Malin..
9
More tweets
Qtime:60
Chart MALIN CORPORATION PLC
Duration : Period :
Malin Corporation plc Technical Analysis Chart | MLCM | IE00BVGC3741 | 4-Traders
Technical analysis trends MALIN CORPORATION PLC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price -
Spread / Average Target -100%
Managers
NameTitle
Adrian G. Howd Chief Executive Officer & Executive Director
Kyran McLaughlin Non-Executive Chairman
Neil McLoughlin Chief Operating Officer
Darragh Lyons Chief Financial Officer & Executive Director
Robert Alexander Ingram Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
MALIN CORPORATION PLC-9.02%533
JOHNSON & JOHNSON23.29%377 585
NOVARTIS13.50%226 453
ROCHE HOLDING LTD.5.55%215 760
PFIZER11.58%213 372
MERCK AND COMPANY7.88%173 214